MedTrace Logo

Dexmedetomidine Transdermal System (DMTS) for Post-Operative Analgesia Following Bunionectomy

NCT02953054 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 88

Last updated 2017-10-09

No results posted yet for this study

Summary

The purpose of this study is to evaluate whether the DMTS, compared with a placebo patch, will provide adequate pain relief during the first 3 days following bunionectomy surgery.

Conditions

  • Pain, Postoperative

Interventions

DRUG

DMTS

DMTS applied before surgery and worn for 72 hours

DRUG

Placebo

Matching patches that have no active drug applied before surgery and worn for 72 hours.

Sponsors & Collaborators

  • Premier Research Group plc

    collaborator UNKNOWN

  • Teikoku Pharma USA, Inc.

    lead INDUSTRY

Principal Investigators

  • James Song, MS, MBA · Teikoku Pharma USA, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-22
Primary Completion
2017-07-03
Completion
2017-07-03

Countries

  • Australia

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02953054 on ClinicalTrials.gov